Table II.
Gene | Median value | Quartile | Interquartile range (QU-QL) | |
---|---|---|---|---|
| ||||
25% | 75% | |||
ERCC1 | 0.621 | 0.526 | 0.879 | 0.353 |
BRCA1 | 0.064 | 0.038 | 0.109 | 0.071 |
TYMS | 0.107 | 0.059 | 0.205 | 0.146 |
RRM1 | 0.237 | 0.177 | 0.340 | 0.163 |
TUBB3 | 0.105 | 0.054 | 0.297 | 0.243 |
STMN1 | 1.500 | 1.096 | 2.637 | 1.541 |
TOP2A | 0.160 | 0.082 | 0.348 | 0.266 |
EGFR | 0.507 | 0.285 | 0.957 | 0.672 |
PDGFR | 0.123 | 0.075 | 0.196 | 0.121 |
VEGFR1 | 0.067 | 0.048 | 0.109 | 0.061 |
VEGFR2 | 0.202 | 0.115 | 0.327 | 0.212 |
KIT | 0.179 | 0.091 | 0.309 | 0.218 |
HER2 | 0.294 | 0.154 | 0.466 | 0.312 |
IGF1R | 0.189 | 0.118 | 0.289 | 0.171 |
NSCLC, non-small cell lung cancer; ERCC1, excision repair cross-complementing rodent repair deficiency, complementation group 1; BRCA1, breast cancer 1; TYMS, thymidylate synthetase; RRM1, ribonucleotide reductase M1; TUBB3, tubulin, β 3 class III; STMN1, stathmin 1; TOP2A, topoisomerase II α; EGFR, epidermal growth factor receptor; PDGFR, platelet-derived growth factor receptor; VEGFR1, vascular endothelial growth factor receptor 1; HER2, human epidermal growth factor receptor 2; IGF1R, insulin-like growth factor 1 receptor; QU, upper quartile; QL, lower quartile.